Endosense
ExitedMedical company focused on improving the efficacy;safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias
Total raised
€73M
€73,272,725
Funding rounds
3
Investors
3
distinct backers
Active since
2009-09
latest 2013-02
Funding by year
EUR raised per yearFunding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2013-03-01 | Series C | €3.9M | — | View deal → |
| 2012-11-01 | Series C | €37M | GIMV,Ysios Capital | View deal → |
| 2009-10-01 | Series B | €33M | GIMV,NeoMed,Ysios Capital | View deal → |
Exit
Type
acquisition
Date
Apr 2010
Value
€155M
Acquiror
St. Jude Medical (United States Saint Paul)
Investors
3Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy